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ABSTRACT: This study assessed the effects of probiotic supplementation on spatial learning and memory, long-term po-
tentiation (LTP), paired-pulse facilitation (PPF) ratios, nitric oxide (NO) concentrations, and lipid profiles in a rat model 
of amyloid beta (A)(1-42)-induced Alzheimer’s disease (AD). Forty rats were randomly divided into 4 groups. The sham 
(control and prevention) group received intracerebroventricular (ICV) injections of artificial cerebrospinal fluid, the Alz-
heimer group received ICV injection of A(1-42), and the probiotic+Alzheimer group received 500 mg probiotics daily (15 
×109 colony-forming unit) by gavage for 4 weeks before and 2 weeks after injection of A(1-42). The Morris water maze 
test was performed for evaluation of spatial learning and memory. LTP and PPF ratios were measured to evaluate long- 
term synaptic plasticity and pre-synaptic mechanisms, respectively. The results showed that probiotic supplementation 
significantly improved learning, but not memory impairment, and increased PPF ratios compared to those in the Alzhei-
mer group. Both A(1-42) injection and probiotic supplementation alone did not significantly effect plasma level of NO. 
Probiotic supplementation of rats in the probiotic (6 weeks)+Alzheimer group decreased serum levels of total cholesterol, 
triglyceride, and very low-density lipoprotein-cholesterol significantly compared to the Alzheimer group. The results of 
this study suggest that probiotic supplementation may positively impact learning capacity and LTP in rats with AD, most 
likely via the release of neurotransmitters via presynaptic mechanisms or via a protective effect on serum lipid profiles.
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INTRODUCTION
Alzheimer’s disease (AD) is an irreversible neurodegen-
erative disease that has substantially increased in inci-
dence over the past two decades. In AD, insoluble amy-
loid beta (A) plaques are deposited throughout the cor-
tex and hippocampus (Lecanu et al., 2010; Salari and 
Bagheri, 2016). A plaques aggregation is associated with 
a deficits in spatial learning and memory, and in the syn-
aptic plasticity (Buckner et al., 2005). The hippocampus 
plays a dominant and important role in spatial learning 
and memory, and in synaptic plasticity (Bannerman et al., 
2014).
Synaptic plasticity is a physiological phenomenon that 
is involved in neural activity and the consequental changes 
in synaptic efficacy and neural excitability (Shankar et al., 
2008).
In the laboratory, paired-pulse facilitation (PPF) ratios 
and induction of long-term potentiation (LTP) are funda-
mental protocols used to examine mechanisms of short- 
term and long-term synaptic plasticity, respectively 
(Costa-Mattioli et al., 2009; Zucker and Regehr, 2002). 
PPF is recorded to probe whether pre-synaptic mecha-
nisms may involve mechanisms of LTP expression since 
LTP expression may involve increases in the probability of 
transmitter release from presynaptic terminals (Cazakoff 
and Howland, 2010; Gerges et al., 2003). Induction of 
LTP in the cornu ammonis (CA) 1 area of hippocampus 
by high-frequency stimulation (HFS) reveals an impor-
tant mechanism of synaptic plasticity and memory, for 
266  Rezaeiasl et al.
enhancing the excitatory postsynaptic potentials (fEPSPs) 
of the CA1 area of the hippocampus (Whitlock et al., 
2006). LTP is involved in both post-synaptic and pre-
synaptic mechanisms (Larkman and Jack, 1995). PPF is 
involved in presynaptic mechanisms through inducing 
short-lasting increases in synaptic effectiveness (Lauri et 
al., 2007; Schulz et al., 1995). PPF is used to examine the 
mechanism of LTP expression by increasing release of 
neurotransmitters via presynaptic mechanisms (Lauri et 
al., 2007; Schulz et al., 1995; Schulz et al., 1994).
The possible role of nitric oxide (NO), as an important 
compensatory signaling molecule, for sustaining synap-
tic plasticity in neurodegenerative diseases such as AD 
has been recently examined (Chakroborty et al., 2015; 
Steinert et al., 2010). NO can either facilitate or suppress 
plasticity through biphasic effects on mechanisms involv-
ed in synaptic plasticity, LTP and consolidation of LTP 
(Böger, 2007; Chakroborty et al., 2015; Hosseini et al., 
2010; Yamada et al., 1999).
There is no cure for AD, but there is a limited number 
of therapeutic options. Most of the current treatments are 
palliative and the efficacies of newer therapies remain 
unproven. Use of acetylcholinesterase (AChE) inhibitors, 
including rivastigmine, donepezil, and galantamine or 
memantine (N-methyl-D-aspartate antagonist), is the 
most common clinically effective approach for treatment 
of AD (Grover et al., 2012). Herbal plants are tradition-
ally used to treat cognitive disorders and amnesia, how-
ever their safety and efficacy needs further investigation 
(Man et al., 2008). In recent years, the role of probiotic 
supplements as a therapeutic strategy to improve memory 
function in a rat model of AD has emerged as a novel and 
intriguing area for research (Akbari et al., 2016; Jiang et 
al., 2017). Probiotic supplements are living bacteria of 
the gut which, when used in adequate amounts, benefi-
cially impact the host human or animal by improving 
their intestinal microbial balance (Liang et al., 2015). 
Akbari et al. (2016) showed that a probiotic supplement 
containing Lactobacillus acidophilus, Lactobacillus casei, Bifid-
obacterium bifidum, and Lactobacillus fermentum improved 
impaired spatial learning and memory induced in AD. 
Romo-Araiza et al. (2018) showed that consumption of 
probiotics (Enterococcus faecalis) and prebiotics (agave in-
ulin) for 5 weeks improved synaptic plasticity in middle- 
aged rats. Previous studies have also shown that dietary 
supplements containing multiple species of live Lactoba-
cillus and Bifidobacteria (L. acidophilus CUL60, L. acido-
philus CUL21, B. bifidum CUL20, and Bifidobacterium lactis 
CUL34) can affect brain functions (O’Hagan et al., 2017). 
Since probiotic supplementation may be associated with 
beneficial effects on AD, the aim of the present study was 
to examine the impact of a long-term dietary supplemen-
tation of probiotics containing Lactobacillus and Bifidobac-
terium strains on learning and memory, electrophysiology 
(LTP and PPF), NO concentrations, and plasma lipid pro-
files in a rat model of A(1-42)-induced AD.
MATERIALS AND METHODS
Male Sprague-Dawley rats weighing 220∼250 g were 
housed with free access to standard rat chow diet and tap 
water for one week in an animal care center (Physiology 
Research Center, Kashan University of Medical Sciences, 
Kashan, Iran). Rats were subjected to a 12-h light/dark 
cycle under controlled temperatures (22±1oC).
Forty male rats were randomly divided into 4 groups: 
control rats without any surgical or diet intervention; 
sham-operated rats that received 20 L artificial cerebro-
spinal fluid (aCSF) through intracerebroventricular (ICV) 
bilateral injection for two consecutive days (10 L/d); 
Alzheimer group rats that recieved 20 g/20 L of A(1- 
42) injected through ICV for two consecutive days; and 
probiotic+Alzheimer group rats that received 500 mg 
probiotics [15×109 colony-forming units (CFU)] for 4 
weeks before and for 2 weeks after injection of A(1-42). 
Spatial learning and memory was evaluated by a Morris 
water maze (MWM). PPF ratios (fEPSP2/fEPSP1) before 
induction of HFS were measured before HFS was in-
duced, and was then continuously recorded for 120 min 
after induction of LTP. At the end of the experiments, 
blood samples were collected from the right atrium and 
was stored at −70oC until further analyses. The study 
protocol was approved by the research ethics committee 
of Kerman University of Medical Sciences (Ethics com-
mittee approval number: IR.KMU.REC.1395.1027). 
A(1-42) preparation
A(1-42) was purchased from Sigma-Aldrich Co. (St. 
Louis, MO, USA). A was dissolved in distilled water at 
1 g/1 L concentration, incubated at 37oC for one week 
and stored at −20oC.
Probiotic preparation
Odorless and colorless probiotic supplement powder (Ira-
nian Prodigest Capsule) composed of L. acidophilus, B. bi-
fidum, and B. longum was purchased from Gostaresh Milad 
Pharmed Co. (Teheran, Iran). Five hundred milligrams of 
the compound (containing 15×109 CFU) was dissolved 
in 1 mL of drinking water. Due to its special components, 
the solution was gavaged immediately after its prepara-
tion daily.
Surgery procedure
In this study, we established an experimental model of 
AD similar to that described in previous studies (Liang 
et al., 2014; Prakash and Kumar, 2014). Briefly, two chan-
nels (23-gauge stainless steel) were implanted into ICV 
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(anterior-posterior: −0.8 mm, left-right: ±1.6 mm, and 
dorsal-ventral: 3.5 mm) using a stereotaxic technique. 
Animals were then allowed to recover for at least one 
week. For ICV injection of A and aCSF, a 30-gauge nee-
dle connected to a microsyringe (10 L) with polyethy-
lene-10 tubing was inserted into a preimplanted cannula 
in each conscious, free moving rat. A and aCSF were 
then slowly injected (5 L/15 min) into each lateral ven-
tricular.
Behavioral test
MWM test was used for evaluation of spatial learning and 
memory. The water maze comprised of a circular tank 
(140 cm diameter, 60 cm high, and 40 cm deep and filled 
with 22±1oC water). The MWM test was performed in a 
room with indirect lighting with an optimal number of 
surrounding cues. A hidden square black platform or es-
cape platform (10 cm diameter) was submerged 1.5∼2.0 
cm beneath the water surface in the middle of the target 
quadrant of the pool. Animal motions were recorded and 
data were sent to a computer via a camera fixed above 
the center of the maze. Commercial software (version: 6 
XT, Noldus Information Technology, Wageningen, The 
Netherlands) was used to measure the escape latency, 
distance travelled, swimming speed, and the number of 
crossings to the target quadrant during training and 
probe trials.
Spatial learning phase: Each training trial consisted of 4 tri-
als per day for 4 consecutive days. In each trail, rats were 
gently released from the start position in the maze North 
(N), South (S), West (W), and East (E) at the middle of 
the circular edge of a randomly selected quadrant, with 
their noses pointed toward the wall. Rats were allowed 
to swim for a maximum duration of 90 s to find the hid-
den platform, with an inter-trial interval of 10 min. The 
mean latency time to find the hidden platform of the wa-
ter maze task was recorded on each day of testing. If the 
animal failed to find the platform within 90 s, it was gen-
tly guided onto the platform. After completion of train-
ing, the animals were returned to their home cages until 
retention testing (probe trial) 24 h later.
Probe trial test (retention testing): The probe trial test was 
performed on day 5, 24 h after the last acquisition day. In 
the probe test, the platform was removed and the rats 
was placed in the start position (S in this study) facing 
the maze wall, as in previous days. Finally, the animals 
were removed after 60 s circulating the tank searching 
for the platform. In probe test, the time spent searching, 
the traveled distance, the swimming speed in the target 
quadrant and the number of crossings to target quadrant 
were recorded.
Electrophysiology
fEPSPs were recorded as an important index of neuronal 
plasticity. The electrophysiological procedure of LTP in-
duction has been previously described (Davari et al., 
2013). Briefly, rats were anesthetized with intraperitoneal 
injections of urethane (1.5 g/kg) and then fixed in a ster-
eotaxic apparatus (Borj Sanat, Tehran, Iran). The record-
ing (3.8 mm posterior to bregma and 2.5 mm lateral to 
the midline) and stimulating electrodes (4.2 mm poste-
rior to bregma and 3.8 mm lateral to the midline) were 
inserted into the CA1 stratum radiatum and Schaffer col-
lateral, respectively, according to the atlas of Paxinos and 
Watson (2005). fEPSPs were recorded following stim-
ulation to the Schaffer collateral pathway. Baseline stim-
ulation was delivered every 30 s. The baseline consisted 
of 200 s pulses of a fixed duration with an amplitude 
varying from 50 to 300 A. Input-output curves were 
constructed before induction of HFS by increasing stim-
ulus intensity in 5∼10 A increments. For induction of 
LTP, stimulus intensity was regulated to evoke a fEPSP 
about 60% of the maximal response of basal fEPSP. Be-
fore and after induction of LTP, we recorded PPF ratios 
for 5 min. Paired-pulses were delivered at 50 ms-intervals 
in the Schaffer collateral pathway. The PPF ratio (fEPSP2/ 
fEPSP1) was fEPSP1, the response evoked by the first 
pulse divided by fEPSP2, the response evoked by the sec-
ond pulse. After recording PPF, LTP was induced by HFS 
at 100 Hz. The HFS protocol consisted of 10 bursts of 
10 stimuli, of 200 s duration, and with a pulse cycle of 
10,000 s. fEPSP in response to HFS was then recorded 
for 120 min. fEPSP were amplified on a preamplifier 
(Electromadule, Well Services of Iran, Tehran, Iran) and 
filtered at 1∼3,000 Hz.
Measurement of biochemical parameters and plasma NO
Blood samples were pooled from the right atrium of all 
animals after electrophysiological experiments were com-
pleted. Blood samples were centrifuged at 2,500 rpm for 5 
min and plasma samples were kept frozen at −80oC until 
further use. Plasma levels of NO were quantified by the 
Griess method (Tatsch et al., 2011). Plasma levels of total 
cholesterol (TC), triglyceride (TG) (Hosseini et al., 2010), 
and very low-density lipoprotein-cholesterol (VLDL-C) 
were measured in rats that were pretreated with probi-
otics for 6 weeks before injection of A(1-42) by using 
standard laboratory kits purchased from Parsazmun Co. 
(Karaj, Iran). VLDL-C levels was estimated from data on 
TG concentrations in plasma according to the following 
formula: VLDL=TG/5.
Statistical analysis
Results were expressed as mean±standard error of the 
mean (SEM). Data were analyzed by SPSS 16 (SPSS Inc., 
Chicago, IL, USA) and Prism 6.0 software (GraphPad, 
San Diego, CA, USA). Differences between two or more 
groups were evaluated using the paired Student’s t-test 
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Fig. 1. The effects of probiotic supplementation on spatial learning and memory in a rat model of amyloid beta (A)(1-42)-induced 
Alzheimer’s disease (AD). Rats in Alzheimer (Alz)+probiotic group received 500 mg probiotics [15×109 colony-forming units (CFU)] 
for 4 weeks before and 2 weeks after injection of A(1-42). (A) Escape latency, (B) total average of escape latency, (C) speed, 
and (D) distance to find the hidden platform in DAY 2∼4 in experimental model of AD in rats was significantly different from 
control or sham groups. Treatment with probiotics significantly changed delay and speed but not distance to find the hidden 
platform in compare with Alz group. The time spent in target quadrant (E) and cross number (H), but not speed (F) and distance 
(G) in probe, in Alz group was significantly different from sham group. Treatment with probiotics did not change any parameters 
measured in probe day in compare with Alz group. Significant difference with sham group at *P<0.05, **P<0.01, and ***P<0.001, 
and significant difference between Alz+probiotic group and Alz group at #P<0.05, ##P<0.01, and ###P<0.001.
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Fig. 2. The effects of probiotic supplementation on long-term 
potentiation (LTP) and field excitatory postsynaptic potentials 
(fEPSPs) in a rat model of Alzheimer’s disease (AD). Rats re-
ceived 500 mg probiotics [15×109 colony-forming units (CFU)] 
for 4 weeks before and 2 weeks after injection of amyloid beta 
(A)(1-42). Probiotic supplementation reversed hippocampal 
LTP suppression induced by A(1-42) (A and B). Moreover, a 
continuous significant increase in fEPSP amplitude was ob-
served in mentioned treatment group, during the 120 min peri-
od following LTP induction (C). Typical representative traces of 
fEPSP on top of time course diagram were obtained 30 min 
before (black traces) and 120 min (red traces) after the induc-
tion of LTP. Alz, Alzheimer group; HFS, high-frequency stimu-
lation. Significant difference with sham group at ***P<0.001 
and significant difference between Alz+probiotic group and Alz 
group at ###P<0.001.
or one-way ANOVA followed by LSD’ post hoc, respec-
tively. Statistical significance was defined as P<0.05.
RESULTS
Effects of probiotic supplement on spatial learning and 
memory
The MWM behavioral test was performed to assess the 
rats’ spatial learning and memory abilities. The escape la-
tency (the ability of animals to find the platform) during 
the four consecutive training days are shown in Fig. 1A. 
Injection of A (ICV) increased escape latency on days 
of 1, 2, 3, and 4 significantly in comparison with the con-
trol and sham groups [(DAY1: F3, 144=11.33; P<0.001), 
(DAY2: F3, 144=3.63; P<0.014), (DAY3: F3, 144=2.78; 
P<0.043), and (DAY4: F3, 144=9.09; P<0.001)]. The es-
cape latency and total distance travelled (DAY2∼DAY4) 
to find the hidden platform was significantly increased in 
the Alzheimer group compared to the control and sham 
groups (Fig. 1B and 1C: F3, 440=12.17; P<0.001). Treat-
ment with probiotic supplement (500 mg/6 weeks/gav-
age) decreased escape latency significantly (P<0.001), 
but did not significantly affect total distance travelled to 
find the hidden platform compared to sham rats (P< 
0.228). The mean time spent in the target quadrant was 
also significantly higher for the Alzheimer group then the 
sham group (F2, 23=9.49; P<0.001), but no significant 
differences were observed between the probiotic (6 
weeks)+Alzheimer group and the Alzheimer group (Fig. 
1D, P<0.96). There were also no significant differences 
in the swimming speed, the travelled distance in the tar-
get quadrant and the number of times the rats crossed 
the platform area between the all 3 groups (Fig. 1E∼1H, 
P≥0.05).
Effects of probiotic supplementation on LTP in the CA1 
area of the hippocampus
In vivo, LTP measurements were performed to evaluate 
synaptic plasticity. fEPSPs was recorded 30 min before, 
continuously during, and for 120 min after the induction 
of LTP. fEPSPs amplitudes were then calculated as a per-
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Fig. 3. The effects of probiotic supplementation on paired-pulse facilitation (PPF) change in a rat model of Alzheimer’s disease 
(AD). Paired-pulse facilitation (PPF) was measured before and 120 min after long-term potentiation (LTP) induction in different 
groups. The PPF ratio was expressed as the field excitatory postsynaptic potentials (fEPSP) 2/fEPSP1 is the response evoked 
by the first pulse and fEPSP2 is the response evoked by the second pulse. Representative trace of PPF is shown on the top 
of the graph (A). There was no significant difference in PPF before and after induction of LTP in each group (B). The % PPF 
change was measured as % PPF change=(PPF ratio after LTP−PPF ratio before LTP)/(PPF ratio before LTP). Data showed that 
induction of LTP produced a significant difference between % PPF change between groups (C). Data are presented as mean±SEM.
Significant difference between sham group and Alzheimer (Alz) group at ***P<0.001 and between Alz group and Alz+probiotic 
group at ###P<0.001.
Fig. 4. The effect of probiotic supplementation on nitric oxide 
(NO) concentration in a rat model of Alzheimer’s disease (AD). 
There is no significant difference in NO concentration between 
groups. Data are presented as mean±SEM.
cent of baseline.
Data showed that the fEPSPs amplitudes differ signifi-
cantly between groups (Fig. 2A and 2B) (F2, 177=126.39; 
P<0.001). However, the magnitude of fEPSPs were sig-
nificantly lower in the Alzheimer group compared to the 
sham group (P<0.001). The results also showed that 
treatment with probiotics, significantly reversed the de-
crease in fEPSPs amplitude observed in the Alzheimer 
group (Fig. 2B, P<0.001). Moreover, a continuous sig-
nificant increase in fEPSP amplitude was observed in the 
probiotic (6 weeks)+Alzheimer group during the 120 
min period following LTP induction (P<0.001) (Fig. 2C).
Effects of probiotic supplementation on the PPF ratio
In this study, the PPF ratio (% change) was measured 
before and after induction of LTP. Results showed that 
the PPF ratio was significantly increased in the Alzhei-
mer group compared to the sham group (F3, 80=10.75; 
P<0.001), and that this increase could be reversed by 
probiotic supplementation (P<0.001; Fig. 3).
Effects of probiotic supplementation on NO concentrations 
and biochemical parameters
No significant difference in NO concentration were re-
corded between the 3 groups (Fig. 4; P≥0.05). However, 
serum concentrations of TC, TG, and VLDL-C were sig-
nificantly higher in the Alzheimer group compared to the 
sham group (Fig. 5; P<0.01). The serum levels of these 
parameters were reduced in the probiotic (6 week)+Alz-
heimer group compared to the Alzheimer group [TC: 
(F2, 15=16.29; P<0.001), TG and VLDL-C: (F2, 15= 
17.19; P<0.001) (Fig. 5)].
DISCUSSION
Consistent with previous studies, these results show that 
A(1-42) injection is associated with learning and mem-
ory impairment (Buckner et al., 2005; Pike et al., 2007). 
Probiotic treatment improved learning impairment, but 
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Fig. 5. The effects of probiotic supplementation on lipid profile 
in a rat model of Alzheimer’s disease (AD). Injection of amyloid 
beta (A)(1-42) (intracerebroventricular) significantly increased 
the plasma level of total cholesterol (TC), triglycerides (TG), and 
very low-density lipoprotein-cholesterol (VLDL-C) and treat-
ment with probiotics for 6 weeks before injection of A(1-42) 
significantly decreased all of these factors in plasma. Data are 
presented as mean±SEM. Significant difference with sham 
group at ***P<0.001 and Alzheimer (Alz) group at ##P<0.01 and ###P<0.001.
did not significantly impact spatial memory. Our results 
are in agreement with previous reports indicating that 
consumption of probiotics improves cognitive functions 
in AD patients (Akbari et al., 2016).
Previous studies have also indicated that chronic diet-
ary supplementation with probiotics containing Lactoba-
cillus and Bifidobacterium improves the memory of mid-
dle-aged rats (O’Hagan et al., 2017; Romo-Araiza et al., 
2018). Emerging evidence has suggested a role of the gut 
microbiota and probiotic supplementation in regulating 
cognitive function and metabolic status in AD (Leblhuber 
et al., 2018; Liang et al., 2015; Minter et al., 2016). There 
are several possible mechanisms involved in learning and 
memory deficits caused by injection of A. For example, 
administration of A into the lateral ventricle is consist-
ent with a major reduction of choline acetyltransferase 
(Chateauvieux et al., 2010), that may lead to cholinergic 
synapse dysfunction and cognitive impairment (Nitta et 
al., 1997). Furthermore, previous studies have shown 
that A(1-42) toxicity decreases the number of -amino-
butyric acid (GABA)-ergic and glutaminergic neurons and 
that it may produce complex imbalances in network ac-
tivity and lead to impaired spatial learning (Thorajak et 
al., 2017). Also, deficits in learning and memory in rats 
treated with A(1-42) may be related to cholinergic and 
dopaminergic hypoactivity and reduced levels of brain- 
derived neurotrophic factor (BDNF) proteins in the hip-
pocampus (Itoh et al., 1996; Mozafari et al., 2018).
Our results demonstrated that A(1-42)-induced spa-
tial learning impairment can be improved by pretreatment 
with probiotics including in L. acidophilus, B. bifidum, and 
B. longum. In agreement with our findings, other studies 
have shown that probiotic supplements containing the 
Gram-positive Lactobacillus and Bifidobacterium, the most 
commonly used probiotic microorganisms (Sekhon and 
Jairath, 2010), exert beneficial effects on deficit learning 
and memory via different mechanisms. Barrett et al. 
(2012) reported that Lactobacillus brevis and Bifidobacterium 
dentium can produce GABA by metabolizing glutamate, 
and this correlates with an increase of GABA in the brain. 
Whereas Choi et al. (2015) showed that fermentation of 
Ganoderma lucidum by B. longum increased cognitive en-
hancing activity by stimulating secretion of memory-re-
lated neurotransmitters such as acetylcholine and gluta-
mate, and by inhibiting AChE activity in brain tissues via 
the cholinergic nervous system in scopolamine-induced 
memory impaired rats (Choi et al., 2015). Other studies 
have shown that B. longum up-regulates hippocampal ex-
pression of BDNF and plays important roles in improv-
ing learning and memory (Bercik et al., 2011; Bercik et 
al., 2010). The underlying mechanism(s) mediating the 
beneficial effects of probiotics on spatial learning and 
memory were not determined in our study; however, 
some of these aforementioned mechanisms may play an 
important role in improvement the learning deficit ob-
served in Alzheimer group.
Both LTP and PPF are of interest as a potential cellular 
substrates in memory (Larkman and Jack, 1995). LTP is 
a use-dependent form of synaptic plasticity. PPF is de-
fined as an index of presynaptic release of neurotransmit-
ters (Zucker and Regehr, 2002), and is associated with 
LTP (Schulz et al., 1995). Our results associated probi-
otic supplementation with an increase in fEPSP ampli-
tudes following LTP induction; this indirectly suggests 
that the A may impair expression of fEPSPs (1-42), and 
this may be impacted by probiotics. Also, PPF (% change) 
after induction of LTP in the Alzheimer group was sig-
nificantly increased compared to the sham group and was 
significantly decreased in the probiotic groups; presynap-
tic neurotransmitter release in the hippocampal CA1 re-
gion of rats may therefore be affected by A(1-42) (Bous-
sicault et al., 2016; Soheili et al., 2015) and probiotic 
treatment may positively impact these changes. Accord-
ingly, our results showed a possible interaction between 
PPF ratios and LTP. LTP expression in Alzheimer group 
decreased release of neurotransmitters after induction of 
LTP, leading to a decrease in fEPSP amplitude. Probiotic 
treatment presumably caused an increase in release of 
presynaptic neurotransmitters, resulting in an increase 
in LTP in the probiotic (6 weeks)+Alzheimer group. In 
agreement with this study, Romo-Araiza et al. (2018) 
showed that probiotic and prebiotic supplementation was 
associated with an improved spatial learning and memo-
ry and significant increases in LTP in middle-aged rats. 
Davari et al. (2013) also reported that probiotic supple-
mentation of streptozotocin-induced diabetic rats im-
proved impaired spatial memory and helped reverse the 
declines in hippocampal LTP.
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Our results did not show any significant differences in 
NO concentration between the Alzheimer and sham 
groups. Contrary to our results, increasing evidence has 
indicated that NO is involved in that pathogenesis of 
some neurodegenerative diseases including AD, either as 
a neuroprotective or neurotoxic agent (Chakroborty et al., 
2015; Nathan et al., 2005).
Furthermore, our results indicate that A(1-42) injec-
tion leads to a significant increase in level of serum TC, 
TG, and VLDL-C, as compared to sham controls. Pretreat-
ment with probiotics for six weeks before induction of 
AD by A(1-42) was associated with significant changes 
in aforementioned biochemical parameters as compared 
to the sham group. However, Grossi et al. (2018) did not 
report any significant differences in TC, high-density lip-
oprotein-cholesterol, or low-density lipoprotein-choles-
terol levels between patients with AD and those without; 
however, in this study TG levels were reported to be low-
er in AD patients than controls. In addition, Akbari et al. 
(2016) showed that treatment with probiotics for 12 
weeks in patients with AD positively impacts cognitive 
function, but is not associated with any significant 
changes in lipid profiles. High level of cholesterol play a 
dominant role in production of A in AD (Boussicault et 
al., 2016) and cholesterol-lowering drugs (statins) may 
decrease the prevalence of AD (Loera-Valencia et al., 
2019). Since the effects of supplementation with probi-
otic on lipid profiles and biochemical parameters is con-
troversial, further animal and human research is needed 
to determine the effects of acute, subacute and chronic 
probiotic supplementation (used either as pre-treatment 
or treatment) on biochemical parameters.
In summary, our results show that A(1-42) induces 
learning and memory impairment, significantly increases 
PPF ratios following LTP induction, and decreases in 
fEPSP amplitudes in A(1-42)-induced Alzheimer group. 
Furthermore, supplementation probiotics improved learn-
ing, but not memory. The probiotics also increased fEPSP 
amplitudes and decreased PPF ratios, suggestive of an in-
crease in presynaptic neurotransmitter release. Further 
studies are needed to elucidate the underlying mecha-
nisms of probiotic supplements on learning and memory.
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